1 citations
,
January 1998 in “Seminars in Plastic Surgery” Hair transplantation using micro- and minigraft megasessions is safe, effective, and provides natural results with high patient satisfaction.
5 citations
,
January 2021 in “Frontiers in Cell and Developmental Biology” This study found that elevated expression of the protein Zyxin in hair follicles is associated with androgenetic alopecia and suggests it may be targeted for therapy.
August 2025 in “Journal of Cosmetic Dermatology” This study reported that hair transplantation using the FUE technique improves mid-upper facial proportions and the forehead contour in East Asian women with high and wide foreheads, yielding high patient satisfaction and favorable safety outcomes.
March 2024 in “Skin research and technology” This study reported that newly established dermoscopic diagnostic and grading criteria for androgenetic alopecia are highly accurate, with sensitivity and specificity at 98.3% and 96.7%, respectively.
24 citations
,
December 1990 in “Pediatric Dermatology” This study observed that hair casts, seen in girls with tightly drawn hairstyles, may result from local circulatory disturbances and scalp inflammation.
In this study, chronic telogen effluvium was identified as the most common cause of alopecia in patients with systemic lupus erythematosus, with trichoscopy proving effective in diagnosing different alopecia patterns.
July 2020 in “Zenodo (CERN European Organization for Nuclear Research)” This study found that cicatricial alopecia in the Libyan community primarily affects middle-aged individuals, especially women, highlighting the importance of early diagnosis and treatment to reduce its impact.
11 citations
,
August 2021 in “Stem Cell Research & Therapy” This study reports that a single transplantation of autologous stromal vascular fraction significantly increased hair density and keratin score in androgenic alopecia patients within six months.
7 citations
,
January 2012 in “International Journal of Trichology” This report describes three patients with distinct conditions who exhibited rectangular-patterned occipital alopecia areata associated with their respective medical cases.
4 citations
,
April 2024 in “Journal of Drugs in Dermatology” In this case report, a severe case of pediatric alopecia areata was treated with topical ruxolitinib, a Janus kinase inhibitor, highlighting the limited but promising evidence for this treatment in children.
4 citations
,
January 2019 in “Archives of clinical and medical case reports” Combining FUE hair transplantation with PRP improves hair density and patient satisfaction in scarring alopecia.
1 citations
,
June 2022 in “Journal of Clinical Oncology” This study found that oral minoxidil may improve hair density in cancer survivors experiencing late alopecia due to chemotherapy and/or endocrine therapy, with patients tolerating the treatment well.
January 2026 in “Dermatologica Sinica” In this study, oral minoxidil (1.25 mg and 2.5 mg) and topical 5% minoxidil significantly promoted hair regrowth in men with androgenetic alopecia over six months, showing comparable efficacy across both oral and topical treatments.
February 2025 in “PubMed” This case series found that trichoscopy and biopsy of the scalp in individuals with skin of color identified concurrent lichen planopilaris and female androgenic alopecia, highlighting the importance of comprehensive scalp evaluation to ensure accurate diagnosis and effective treatment.
March 2022 in “Annals of Bariatric Surgery” This study found that protein supplements combined with micronutrients reduced hair loss more effectively after sleeve gastrectomy in women, compared to routine multivitamins alone.
17 citations
,
October 2024 in “Journal of the American Academy of Dermatology” In this study, brepocitinib was found to significantly reduce inflammatory biomarker CCL5 expression and improve clinical severity by week 24, while maintaining a favorable safety profile.
4 citations
,
February 2022 in “International Journal of Molecular Sciences” This review discusses the similarities between myotonic dystrophy and aging, highlighting the role of cellular senescence in its pathophysiology, and reports no new clinical findings; the authors note potential anti-aging therapy applications.
March 2023 in “Civil Medical Journal” This observational study found that 37% of male patients with androgenetic alopecia had a history of preceding COVID-19 infection, suggesting a potential link between the two.
10 citations
,
June 2019 in “Aesthetic Plastic Surgery” This study observed that amniotic allografts provided similar aesthetic improvements with less downtime and quicker results compared to PRP treatment for midface volume enhancement.
3 citations
,
January 2019 in “Indian Journal of Dermatology” This study observed that transverse sectioning of scalp biopsies may aid in diagnosing different types of alopecia by revealing distinct histopathological features like follicle miniaturization and specific inflammatory patterns.
2 citations
,
September 2021 in “Orphanet Journal of Rare Diseases” In this study, HED patients with COVID-19 showed a higher risk of postinfection fatigue and hair loss compared to controls, suggesting they are more susceptible to long-term consequences of SARS-CoV-2 infection.
September 2025 in “International Journal of Women’s Dermatology” This study found that oral spironolactone 100 mg daily for 24 weeks improved terminal hair counts and diameters in premenopausal women with female pattern hair loss when used alongside minoxidil, despite a higher incidence of menstrual irregularities.
May 2025 in “Journal of the Egyptian Womenʼs Dermatologic Society” This randomized controlled trial found that intralesional vitamin D3 was as effective and safe as intralesional triamcinolone acetonide for treating patchy alopecia areata on the scalp, with no significant influence from serum vitamin D levels on treatment response.
September 2024 in “Journal of Cutaneous and Aesthetic Surgery” This review focuses on the pharmacological properties, indications, contraindications, and safety profile of bicalutamide, a non-steroidal androgen receptor antagonist, in dermatological research, particularly its off-label use for improving female pattern hair loss as measured by Sinclair grading.
March 2024 in “Cosmoderma” This review discusses various extra facial esthetic indications of botulinum toxin, like neck rejuvenation and calf slimming, and reports no clinical results; essential tips for each indication are included.
January 2023 in “Skin appendage disorders” In this review, the authors detailed the clinical, trichoscopic, and histopathological features of hair disorders linked to autoimmune diseases, highlighting the role of dermatologists in identifying possible underlying autoimmune conditions in patients presenting with hair loss.
January 2023 in “International Journal of Trichology” This study found that bicalutamide mesotherapy resulted in subtle hair density improvements and was well tolerated by premenopausal women with androgenetic alopecia.
3 citations
,
January 2019 in “International Journal of Trichology” This study found no statistical difference in thiol-disulfide balance between telogen effluvium patients and controls, suggesting oxidative stress may not affect telogen effluvium through this mechanism.
13 citations
,
May 2015 in “Journal of The American Academy of Dermatology” This study found that oral minoxidil 5 mg daily significantly improves hair growth in men with androgenetic alopecia, although common side effects include hypertrichosis and pedal edema.
January 2020 in “Medpulse International Journal of General Medicine” This study observed that trichoscopic patterns, such as yellow dots and honey comb patterns, correlate with the severity of androgenetic alopecia in Indian patients, highlighting trichoscopy's diagnostic and prognostic value.